 | • レポートコード：C-GIR20G2710 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「女性不妊薬の世界市場2019年」は、グローバルにおける女性不妊薬市場を展望するレポートです。女性不妊薬のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・女性不妊薬の市場概観 ・女性不妊薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・女性不妊薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・女性不妊薬の世界市場規模 ・女性不妊薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・女性不妊薬のアメリカ市場規模推移 ・女性不妊薬のカナダ市場規模推移 ・女性不妊薬のメキシコ市場規模推移 ・女性不妊薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・女性不妊薬のドイツ市場規模推移 ・女性不妊薬のイギリス市場規模推移 ・女性不妊薬のロシア市場規模推移 ・女性不妊薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・女性不妊薬の日本市場規模推移 ・女性不妊薬の中国市場規模推移 ・女性不妊薬の韓国市場規模推移 ・女性不妊薬のインド市場規模推移 ・女性不妊薬の東南アジア市場規模推移 ・女性不妊薬の南米市場分析（ブラジル、アルゼンチン等） ・女性不妊薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・女性不妊薬の種類別分析/販売量、売上、市場シェア（非経口、経口、その他） ・女性不妊薬の用途別分析/市場規模（卵巣過刺激症候群、多胎妊娠、多産児、早産、低出生体重、帝王切開リスク） ・女性不妊薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・女性不妊薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Female Infertility Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Female Infertility Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Female Infertility Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Female Infertility Drugs market by product type and applications/end industries.
Market Segment by Companies, this report covers
Allergan Plc
Novartis AG
Ferring BV
Merck KGaA
Sanofi
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Parenteral
Oral
Others
Market Segment by Applications, can be divided into
Ovarian Hyperstimulation Syndrome
Multiple-gestation Pregnancies
Multiple-birth Infants
Premature Labor
Low Birth Weight
Risk of Cesarean Delivery
Table of Contents
1 Female Infertility Drugs Market Overview
1.1 Product Overview and Scope of Female Infertility Drugs
1.2 Classification of Female Infertility Drugs by Types
1.2.1 Global Female Infertility Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Female Infertility Drugs Revenue Market Share by Types in 2018
1.2.3 Parenteral
1.2.4 Oral
1.2.5 Others
1.3 Global Female Infertility Drugs Market by Application
1.3.1 Global Female Infertility Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Ovarian Hyperstimulation Syndrome
1.3.3 Multiple-gestation Pregnancies
1.3.4 Multiple-birth Infants
1.3.5 Premature Labor
1.3.6 Low Birth Weight
1.3.7 Risk of Cesarean Delivery
1.4 Global Female Infertility Drugs Market by Regions
1.4.1 Global Female Infertility Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Female Infertility Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Female Infertility Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Female Infertility Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Female Infertility Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Female Infertility Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Female Infertility Drugs (2014-2024)
2 Company Profiles
2.1 Allergan Plc
2.1.1 Business Overview
2.1.2 Female Infertility Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Plc Female Infertility Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis AG
2.2.1 Business Overview
2.2.2 Female Infertility Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis AG Female Infertility Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 Ferring BV
2.3.1 Business Overview
2.3.2 Female Infertility Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Ferring BV Female Infertility Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Merck KGaA
2.4.1 Business Overview
2.4.2 Female Infertility Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck KGaA Female Infertility Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Sanofi
2.5.1 Business Overview
2.5.2 Female Infertility Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Female Infertility Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Female Infertility Drugs Market Competition, by Players
3.1 Global Female Infertility Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Female Infertility Drugs Players Market Share
3.2.2 Top 10 Female Infertility Drugs Players Market Share
3.3 Market Competition Trend
4 Global Female Infertility Drugs Market Size by Regions
4.1 Global Female Infertility Drugs Revenue and Market Share by Regions
4.2 North America Female Infertility Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Female Infertility Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Female Infertility Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Female Infertility Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Female Infertility Drugs Revenue and Growth Rate (2014-2019)
5 North America Female Infertility Drugs Revenue by Countries
5.1 North America Female Infertility Drugs Revenue by Countries (2014-2019)
5.2 USA Female Infertility Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Female Infertility Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Female Infertility Drugs Revenue and Growth Rate (2014-2019)
6 Europe Female Infertility Drugs Revenue by Countries
6.1 Europe Female Infertility Drugs Revenue by Countries (2014-2019)
6.2 Germany Female Infertility Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Female Infertility Drugs Revenue and Growth Rate (2014-2019)
6.4 France Female Infertility Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Female Infertility Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Female Infertility Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Female Infertility Drugs Revenue by Countries
7.1 Asia-Pacific Female Infertility Drugs Revenue by Countries (2014-2019)
7.2 China Female Infertility Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Female Infertility Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Female Infertility Drugs Revenue and Growth Rate (2014-2019)
7.5 India Female Infertility Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Female Infertility Drugs Revenue and Growth Rate (2014-2019)
8 South America Female Infertility Drugs Revenue by Countries
8.1 South America Female Infertility Drugs Revenue by Countries (2014-2019)
8.2 Brazil Female Infertility Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Female Infertility Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Female Infertility Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Female Infertility Drugs by Countries
9.1 Middle East and Africa Female Infertility Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Female Infertility Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Female Infertility Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Female Infertility Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Female Infertility Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Female Infertility Drugs Revenue and Growth Rate (2014-2019)
10 Global Female Infertility Drugs Market Segment by Type
10.1 Global Female Infertility Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Female Infertility Drugs Market Forecast by Type (2019-2024)
10.3 Parenteral Revenue Growth Rate (2014-2024)
10.4 Oral Revenue Growth Rate (2014-2024)
10.5 Others Revenue Growth Rate (2014-2024)
11 Global Female Infertility Drugs Market Segment by Application
11.1 Global Female Infertility Drugs Revenue Market Share by Application (2014-2019)
11.2 Female Infertility Drugs Market Forecast by Application (2019-2024)
11.3 Ovarian Hyperstimulation Syndrome Revenue Growth (2014-2019)
11.4 Multiple-gestation Pregnancies Revenue Growth (2014-2019)
11.5 Multiple-birth Infants Revenue Growth (2014-2019)
11.6 Premature Labor Revenue Growth (2014-2019)
11.7 Low Birth Weight Revenue Growth (2014-2019)
11.8 Risk of Cesarean Delivery Revenue Growth (2014-2019)
12 Global Female Infertility Drugs Market Size Forecast (2019-2024)
12.1 Global Female Infertility Drugs Market Size Forecast (2019-2024)
12.2 Global Female Infertility Drugs Market Forecast by Regions (2019-2024)
12.3 North America Female Infertility Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Female Infertility Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Female Infertility Drugs Revenue Market Forecast (2019-2024)
12.6 South America Female Infertility Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Female Infertility Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Female Infertility Drugs Picture
Table Product Specifications of Female Infertility Drugs
Table Global Female Infertility Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Female Infertility Drugs Revenue Market Share by Types in 2018
Figure Parenteral Picture
Figure Oral Picture
Figure Others Picture
Table Global Female Infertility Drugs Revenue (Million USD) by Application (2014-2024)
Figure Female Infertility Drugs Revenue Market Share by Applications in 2018
Figure Ovarian Hyperstimulation Syndrome Picture
Figure Multiple-gestation Pregnancies Picture
Figure Multiple-birth Infants Picture
Figure Premature Labor Picture
Figure Low Birth Weight Picture
Figure Risk of Cesarean Delivery Picture
Table Global Market Female Infertility Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Female Infertility Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Female Infertility Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Female Infertility Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Female Infertility Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Female Infertility Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Female Infertility Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Allergan Plc Basic Information, Manufacturing Base and Competitors
Table Allergan Plc Female Infertility Drugs Type and Applications
Table Allergan Plc Female Infertility Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Female Infertility Drugs Type and Applications
Table Novartis AG Female Infertility Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Ferring BV Basic Information, Manufacturing Base and Competitors
Table Ferring BV Female Infertility Drugs Type and Applications
Table Ferring BV Female Infertility Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Merck KGaA Basic Information, Manufacturing Base and Competitors
Table Merck KGaA Female Infertility Drugs Type and Applications
Table Merck KGaA Female Infertility Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Female Infertility Drugs Type and Applications
Table Sanofi Female Infertility Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Female Infertility Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Female Infertility Drugs Revenue Share by Players (2014-2019)
Figure Global Female Infertility Drugs Revenue Share by Players in 2017
Figure Global Female Infertility Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Female Infertility Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Female Infertility Drugs Revenue Market Share in 2018
Figure Global Female Infertility Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Female Infertility Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Female Infertility Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Female Infertility Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Female Infertility Drugs Revenue Market Share by Regions in 2018
Figure North America Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure South America Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Table North America Female Infertility Drugs Revenue by Countries (2014-2019)
Table North America Female Infertility Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Female Infertility Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Female Infertility Drugs Revenue Market Share by Countries in 2018
Figure USA Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Table Europe Female Infertility Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Female Infertility Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Female Infertility Drugs Revenue Market Share by Countries in 2018
Figure Germany Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure UK Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure France Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Female Infertility Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Female Infertility Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Female Infertility Drugs Revenue Market Share by Countries in 2018
Figure China Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure India Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Table South America Female Infertility Drugs Revenue by Countries (2014-2019)
Table South America Female Infertility Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Female Infertility Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Female Infertility Drugs Revenue Market Share by Countries in 2018
Figure Brazil Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Female Infertility Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Female Infertility Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Female Infertility Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Female Infertility Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Female Infertility Drugs Revenue and Growth Rate (2014-2019)
Table Global Female Infertility Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Female Infertility Drugs Revenue Share by Type (2014-2019)
Figure Global Female Infertility Drugs Revenue Share by Type (2014-2019)
Figure Global Female Infertility Drugs Revenue Share by Type in 2018
Table Global Female Infertility Drugs Revenue Forecast by Type (2019-2024)
Figure Global Female Infertility Drugs Market Share Forecast by Type (2019-2024)
Figure Global Parenteral Revenue Growth Rate (2014-2019)
Figure Global Oral Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Female Infertility Drugs Revenue by Application (2014-2019)
Table Global Female Infertility Drugs Revenue Share by Application (2014-2019)
Figure Global Female Infertility Drugs Revenue Share by Application (2014-2019)
Figure Global Female Infertility Drugs Revenue Share by Application in 2018
Table Global Female Infertility Drugs Revenue Forecast by Application (2019-2024)
Figure Global Female Infertility Drugs Market Share Forecast by Application (2019-2024)
Figure Global Ovarian Hyperstimulation Syndrome Revenue Growth Rate (2014-2019)
Figure Global Multiple-gestation Pregnancies Revenue Growth Rate (2014-2019)
Figure Global Multiple-birth Infants Revenue Growth Rate (2014-2019)
Figure Global Premature Labor Revenue Growth Rate (2014-2019)
Figure Global Low Birth Weight Revenue Growth Rate (2014-2019)
Figure Global Risk of Cesarean Delivery Revenue Growth Rate (2014-2019)
Figure Global Female Infertility Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Female Infertility Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Female Infertility Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Female Infertility Drugs Revenue Market Forecast (2019-2024)
Figure Europe Female Infertility Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Female Infertility Drugs Revenue Market Forecast (2019-2024)
Figure South America Female Infertility Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Female Infertility Drugs Revenue Market Forecast (2019-2024)
不妊治療市場：世界及び中国市場分析・予測（～2024年） Infertility Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Infertility Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Infertility Treatment manu…- 男性不妊症用診断及び治療市場：世界及び中国市場分析・予測（～2024年） Male Infertility Diagnosis and Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Male Infertility Diagnosis and Treatment industry with a focus on the Chinese market. The report provides key statistics on the market st…
- 世界の女性医療用医薬品市場予測（～2024年）：メーカー別、地域別、種類・用途別 Women's health drug is the health drug specifically for women. Scope of the Report: The worldwide market for Women's Health Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info…
- 世界の女性オナニスト市場予測（～2024年）：メーカー別、地域別、種類・用途別 Feale masturbator is a device designed to imitate the male sex organ. To achieve this, it will generally be made of a soft material, lubricated, and sometimes heated. Scope of the Report: The worldwide market for Female Masturbator is expected to grow at a CAGR of roughly xx% over the next five year…
- 世界の女性用スキンケア市場予測（～2024年） Female Skincare is a booming industry, as every female wants flawless skin. The Female Skincare consists of facial care, body care, hand care, depilatories and make-up remover products Scope of the Report: The worldwide market for Female Skincare is expected to grow at a CAGR of roughly xx% over the…